Kuros Biosciences AG (KURN) — Capital Reinvestment Ratio

Latest as of December 2025: 0.53x

Kuros Biosciences AG (KURN) has a Capital Reinvestment Ratio of 0.53x as of December 2025, meaning it reinvests 1% of its operating cash flow (CHF1.94 Million) in capital expenditures (CHF1.03 Million). Check Kuros Biosciences AG (KURN) tangible net worth to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.53x

Capex / Operating Cash Flow

Operating Cash Flow

CHF1.94 Million

CHF

Capital Expenditures

CHF1.03 Million

CHF

Data as of

Dec 2025

Most recent filing

Kuros Biosciences AG Capital Reinvestment Ratio (2024–2024)

This chart tracks Kuros Biosciences AG's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Kuros Biosciences AG operating cash flow efficiency.

Annual Capital Reinvestment Ratio for Kuros Biosciences AG (2024–2024)

Year-by-year Capital Reinvestment Ratio for Kuros Biosciences AG from 2024 to 2024. See cash generation quality of Kuros Biosciences AG to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (CHF)	Capital Expenditures	YoY Change
2024	0.35x	CHF3.14 Million	CHF1.11 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow